Vicore Pharma (Sweden) Technical Analysis
| VICO Stock | SEK 7.91 0.13 1.67% |
As of the 23rd of November, Vicore Pharma has the Variance of 45.08, risk adjusted performance of (0.08), and Coefficient Of Variation of (856.75). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vicore Pharma Holding, as well as the relationship between them.
Vicore Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vicore, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VicoreVicore |
Vicore Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Vicore Pharma Holding Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vicore Pharma Holding volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Vicore Pharma Holding Trend Analysis
Use this graph to draw trend lines for Vicore Pharma Holding. You can use it to identify possible trend reversals for Vicore Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vicore Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Vicore Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Vicore Pharma Holding applied against its price change over selected period. The best fit line has a slop of 0.06 , which may suggest that Vicore Pharma Holding market price will keep on failing further. It has 122 observation points and a regression sum of squares at 114.49, which is the sum of squared deviations for the predicted Vicore Pharma price change compared to its average price change.About Vicore Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vicore Pharma Holding on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vicore Pharma Holding based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vicore Pharma Holding price pattern first instead of the macroeconomic environment surrounding Vicore Pharma Holding. By analyzing Vicore Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vicore Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vicore Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Vicore Pharma November 23, 2024 Technical Indicators
Most technical analysis of Vicore help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vicore from various momentum indicators to cycle indicators. When you analyze Vicore charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.69) | |||
| Mean Deviation | 2.65 | |||
| Coefficient Of Variation | (856.75) | |||
| Standard Deviation | 6.71 | |||
| Variance | 45.08 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.85) | |||
| Treynor Ratio | (0.70) | |||
| Maximum Drawdown | 52.59 | |||
| Value At Risk | (4.36) | |||
| Potential Upside | 3.39 | |||
| Skewness | (5.73) | |||
| Kurtosis | 42.94 |
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.